---
figid: PMC7661400__40292_2020_414_Fig1_HTML
figlink: pmc/articles/PMC7661400/figure/Fig1/
number: F1
caption: Possible mechanisms for the activation of innate immunity in Fabry disease
  and hypertension. Exogenous (e.g. LPS) and endogenous (e.g., glycosphingolipids)
  ligands elicit innate immunity response by binding to TLR4. In turn, TLR4 stimulates
  NADPH oxidase and the transcription of pro-inflammatory cytokines. The resulting
  pro-oxidant, pro-inflammatory environment leads to anatomical changes (e.g., smooth
  muscle cells hypertrophy; fibrosis) and functional impairment (e.g., impaired vasoreactivity;
  glomerular dysfunction). See text for further details. PAMPs pathogen-associated
  molecular patterns, DAMPs damage-associated molecular patterns, LPS lipopolysaccharide,
  LDL low-density lipoproteins, Ang II angiotensin II, HSP heat shock proteins, ECM extracellular
  matrix, Gb3 globotriaosylceramide, lyso-Gb3 globotriaosylsphingosine, TLR4 toll-like
  receptor 4, NADPH nicotinamide adenine dinucleotide phosphate, MyD88 myeloid differentiation
  primary response 88, MAPK mitogen-activated protein kinase, NF-kB nuclear factor-kB,
  ROS reactive oxygen species
pmcid: PMC7661400
papertitle: 'The role of Immunity in Fabry Disease and Hypertension: A Review of a
  Novel Common Pathway.'
reftext: Rita Del Pinto, et al. High Blood Press Cardiovasc Prev. 2020;27(6):539-546.
pmc_ranked_result_index: '56530'
pathway_score: 0.9423908
filename: 40292_2020_414_Fig1_HTML.jpg
figtitle: Possible mechanisms for the activation of innate immunity in Fabry disease
  and hypertension
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7661400__40292_2020_414_Fig1_HTML.html
  '@type': Dataset
  description: Possible mechanisms for the activation of innate immunity in Fabry
    disease and hypertension. Exogenous (e.g. LPS) and endogenous (e.g., glycosphingolipids)
    ligands elicit innate immunity response by binding to TLR4. In turn, TLR4 stimulates
    NADPH oxidase and the transcription of pro-inflammatory cytokines. The resulting
    pro-oxidant, pro-inflammatory environment leads to anatomical changes (e.g., smooth
    muscle cells hypertrophy; fibrosis) and functional impairment (e.g., impaired
    vasoreactivity; glomerular dysfunction). See text for further details. PAMPs pathogen-associated
    molecular patterns, DAMPs damage-associated molecular patterns, LPS lipopolysaccharide,
    LDL low-density lipoproteins, Ang II angiotensin II, HSP heat shock proteins,
    ECM extracellular matrix, Gb3 globotriaosylceramide, lyso-Gb3 globotriaosylsphingosine,
    TLR4 toll-like receptor 4, NADPH nicotinamide adenine dinucleotide phosphate,
    MyD88 myeloid differentiation primary response 88, MAPK mitogen-activated protein
    kinase, NF-kB nuclear factor-kB, ROS reactive oxygen species
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - TLR4
  - MYD88
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAGEE1
  - NADPH
  - LPS
  - fibrosis
genes:
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: damage/remodeling/fibrosis
  symbol: DAMAGE
  source: hgnc_alias_symbol
  hgnc_symbol: MAGEE1
  entrez: '57692'
chemicals:
- word: NADPH
  source: MESH
  identifier: D009249
diseases:
- word: LPS
  source: MESH
  identifier: C536528
- word: fibrosis
  source: MESH
  identifier: D005355
figid_alias: PMC7661400__F1
redirect_from: /figures/PMC7661400__F1
figtype: Figure
---
